Puma Biotechnology Inc (NASDAQ:PBYI)
| 3.51 Delayed Data As of Jun 08 |  -0.06 / -1.68%Today’s Change | 2.08 Today|||52-Week Range 5.16 | -17.02% Year-to-Date |
Latest PBYI News | Press Releases
| Bluebird (BLUE) Down 26% Since Last Earnings Report: Can It Rebound? Jun 08 / Zacks.com - Paid Partner Content | PBYI or TECH: Which Is the Better Value Stock Right Now? Jun 01 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 3.57 |
| Today’s open | 3.57 |
| Day’s range | 3.32 - 3.59 |
| Volume | 230,292 |
| Average volume (3 months) | 289,095 |
| Market cap | $165.8M |
Data as of 3:59pm ET, 06/08/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +6.13% |
| Revenue growth (last year) | -9.92% |
| P/E ratio | 31.9 |
| Price/Sales | 0.83 |
| Price/Book | 6.91 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Ecogreen Internation... | 0.00 | 0.00% |
| CRVSCorvus Pharmaceutica... | +0.36 | +10.29% |
| ORMPOramed Pharmaceutica... | -0.04 | -0.99% |
| TBGNFOxurion NV | 0.00 | 0.00% |
Data as of 3:59pm ET, 06/08/2023
Financials
| Next reporting date | August 10, 2023 |
| EPS forecast (this quarter) | $0.01 |
| Annual revenue (last year) | $228.0M |
| Annual profit (last year) | $2.0K |
| Net profit margin | 0.00% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Los Angeles, California |
Forecasts
